文献速递其他结缔组织病

系统性硬化相关肺纤维化支气管肺泡灌洗液蛋白质组学分析:S100A6与14-3-3ε作为潜在生物标志物

Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

该研究对系统性硬化相关肺纤维化(PF-SSc)患者及吸烟与非吸烟对照者的支气管肺泡灌洗液进行功能性蛋白质组学分析,主成分分析显示PF-SSc具有特定蛋白谱,富集分析揭示IL6信号、补体系统、先天免疫、Jak-STAT、激肽释放酶-激肽系统、凝血及吞噬体抗原提呈等通路参与发病,MetaCore网络提示C3a、APOAI、14-3-3ε、SPFA2和S100A6为潜在生物标志物。

要点

  • PF-SSc患者支气管肺泡灌洗液存在特定差异蛋白表达谱。
  • 富集分析提示IL6信号、补体系统、先天免疫等通路参与PF-SSc发病。
  • C3a、APOAI、14-3-3ε、SPFA2和S100A6被网络分析提示为潜在生物标志物。

核心结论

  • 该报告提供了PF-SSc病理过程的分子概览,并指出可能的新疾病生物标志物和治疗靶点。

研究设计与样本

  • 对PF-SSc患者及吸烟和非吸烟对照者的支气管肺泡灌洗液样本进行功能性蛋白质组学分析。

主要发现

  • 主成分分析显示PF-SSc相对于对照样本具有特定的蛋白质谱。
  • 富集分析揭示参与PF-SSc发病的过程网络,涉及IL6信号、补体系统、先天免疫、Jak-STAT、激肽释放酶-激肽系统、凝血、吞噬介导的免疫反应及吞噬体抗原提呈。
  • MetaCore网络分析提示C3a、APOAI、14-3-3ε、SPFA2和S100A6为潜在生物标志物,这些上游分子参与PF-SSc的肺纤维化、先天免疫和血管损伤。

临床怎么用

  • 这些潜在生物标志物可能有助于深入理解PF-SSc的发病机制,并为未来预后评估和治疗靶点开发提供线索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: SSc is a rare severe connective tissue disorder. Its prognosis is mainly related to the development of pulmonary fibrosis (PF)-SSc and pulmonary arterial hypertension. No known therapy for PF-SSc modifies progressive lung fibrotic involvement. Research is therefore aimed at a deeper understanding of complex pathogenetic mechanisms and the possibility of new prognostic biomarkers and therapeutic targets. METHODS: Towards the first of these aims, we conducted functional proteomic analysis of bronchoalveolar lavage samples from PF-SSc patients and smoker and non-smoker controls. RESULTS: The differential expression pattern revealed by principal component analysis highlighted a specific protein profile of PF-SSc with respect to control samples, and enrichment analysis shed light on process networks involved in pathogenesis. The proteins identified are known to be involved in lung inflammation of PF-SSc-induced IL6 signalling, the complement system, innate immunity, Jak-STAT, the kallikrein-kinin system, blood coagulation, the immune response mediated by phagocytosis and phagosomes in antigen presentation. In particular, our MetaCore network suggested C3a, APOAI, 14-3-3ε, SPFA2 and S100A6 as potential biomarkers; these are upstream molecules involved in lung fibrosis, innate immunity and vascular damage occurring in PF-SSc. CONCLUSION: This report provides a molecular overview of pathological processes in PF-SSc, pinpointing possible new disease biomarkers and therapeutic targets.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Landi C, Bargagli E, Carleo A, et al. Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers. Rheumatology (Oxford). 2019. PMID: 30239835. doi:10.1093/rheumatology/key223

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。